NYSE:MDT

Medtronic Stock Forecast, Price & News

$127.84
-0.89 (-0.69 %)
(As of 09/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$127.76
$130.05
50-Day Range
$122.75
$135.17
52-Week Range
$98.94
$135.89
Volume2.98 million shs
Average Volume4.37 million shs
Market Capitalization$171.80 billion
P/E Ratio44.70
Dividend Yield1.96%
Beta0.8
30 days | 90 days | 365 days | Advanced Chart
Receive MDT News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.


Medtronic logo

About Medtronic

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consists of products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Minimally Invasive Technologies Group segment focuses on respiratory system, gastrointestinal tract, renal system, lungs, pelvic region, kidneys, and obesity diseases. The Restorative Therapies Group segment comprises of neurostimulation therapies and drug delivery systems for the treatment of chronic pain, as well as areas of the spine and brain, along with pelvic health and conditions of the ear, nose, and throat. The Diabetes Group segment offers insulin pumps, coninuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

3.10 out of 5 stars

Medical Sector

6th out of 1,352 stocks

Electromedical Equipment Industry

1st out of 31 stocks

Analyst Opinion: 3.4Community Rank: 5.0Dividend Strength: 3.3Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Medtronic (NYSE:MDT) Frequently Asked Questions

Is Medtronic a buy right now?

22 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last twelve months. There are currently 5 hold ratings, 16 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Medtronic stock.
View analyst ratings for Medtronic
or view top-rated stocks.

What stocks does MarketBeat like better than Medtronic?

Wall Street analysts have given Medtronic a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Medtronic wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Medtronic's next earnings date?

Medtronic is scheduled to release its next quarterly earnings announcement on Tuesday, November 23rd 2021.
View our earnings forecast for Medtronic
.

How were Medtronic's earnings last quarter?

Medtronic plc (NYSE:MDT) issued its quarterly earnings data on Monday, August, 23rd. The medical technology company reported $1.41 EPS for the quarter, topping the Zacks' consensus estimate of $1.32 by $0.09. The medical technology company earned $7.99 billion during the quarter, compared to analyst estimates of $7.88 billion. Medtronic had a net margin of 12.29% and a trailing twelve-month return on equity of 13.85%. Medtronic's revenue for the quarter was up 22.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.62 earnings per share.
View Medtronic's earnings history
.

How has Medtronic's stock price been impacted by Coronavirus (COVID-19)?

Medtronic's stock was trading at $92.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MDT shares have increased by 38.3% and is now trading at $127.84.
View which stocks have been most impacted by COVID-19
.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic declared a quarterly dividend on Monday, August 23rd. Stockholders of record on Friday, September 24th will be given a dividend of $0.63 per share on Friday, October 15th. This represents a $2.52 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date is Thursday, September 23rd.
View Medtronic's dividend history
.

Is Medtronic a good dividend stock?

Medtronic pays an annual dividend of $2.52 per share and currently has a dividend yield of 1.96%.
View Medtronic's dividend history.

What guidance has Medtronic issued on next quarter's earnings?

Medtronic updated its FY 2022 earnings guidance on Tuesday, September, 21st. The company provided earnings per share guidance of $5.650-$5.750 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.690. The company issued revenue guidance of -.

What price target have analysts set for MDT?

22 analysts have issued 1 year price objectives for Medtronic's stock. Their forecasts range from $119.00 to $165.00. On average, they expect Medtronic's share price to reach $144.24 in the next twelve months. This suggests a possible upside of 12.8% from the stock's current price.
View analysts' price targets for Medtronic
or view top-rated stocks among Wall Street analysts.

Who are Medtronic's key executives?

Medtronic's management team includes the following people:
  • Geoffrey Straub Martha, Chairman & Chief Executive Officer
  • Gregory L. Smith, Executive VP-Global Operations & Supply Chain
  • Karen L. Parkhill, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
  • Richard E. Kuntz, Chief Medical & Scientific Officer, Senior VP
  • Laura Mauri, Chief Clinical & Regulatory Officer, Senior VP

What is Omar S. Ishrak's approval rating as Medtronic's CEO?

1,925 employees have rated Medtronic CEO Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among Medtronic's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Medtronic's key competitors?

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), The Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), The Home Depot (HD) and Walmart (WMT).

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Who are Medtronic's major shareholders?

Medtronic's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.32%), BlackRock Inc. (7.78%), State Street Corp (4.16%), Massachusetts Financial Services Co. MA (3.43%), Lazard Asset Management LLC (1.83%) and Price T Rowe Associates Inc. MD (1.69%). Company insiders that own Medtronic stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Michael J Coyle, Omar Ishrak, Richard H Anderson, Richard Kuntz, Robert John White and Sean Salmon.
View institutional ownership trends for Medtronic
.

Which major investors are selling Medtronic stock?

MDT stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Boston Partners, BlackRock Inc., Massachusetts Financial Services Co. MA, Franklin Resources Inc., Barrow Hanley Mewhinney & Strauss LLC, Carmignac Gestion, and Wells Fargo & Company MN. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Brett A Wall, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Omar Ishrak, Robert John White, and Sean Salmon.
View insider buying and selling activity for Medtronic
or view top insider-selling stocks.

Which major investors are buying Medtronic stock?

MDT stock was acquired by a variety of institutional investors in the last quarter, including Amundi, Jefferies Group LLC, Sanders Capital LLC, Invesco Ltd., Prospera Financial Services Inc, Canada Pension Plan Investment Board, FMR LLC, and State Street Corp. Company insiders that have bought Medtronic stock in the last two years include Omar Ishrak, and Richard H Anderson.
View insider buying and selling activity for Medtronic
or or view top insider-buying stocks.

How do I buy shares of Medtronic?

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $127.84.

How much money does Medtronic make?

Medtronic has a market capitalization of $171.80 billion and generates $30.12 billion in revenue each year.

How many employees does Medtronic have?

Medtronic employs 90,000 workers across the globe.

When was Medtronic founded?

Medtronic was founded in 1949.

What is Medtronic's official website?

The official website for Medtronic is www.medtronic.com.

Where are Medtronic's headquarters?

Medtronic is headquartered at 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at (531) 438-1700 or via email at [email protected].


This page was last updated on 9/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.